{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:41:44Z","timestamp":1787614904667,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejps.2022.106288","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T11:39:57Z","timestamp":1661600397000},"page":"106288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial"],"prefix":"10.1016","volume":"178","author":[{"given":"Baoshi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106288_bib0001","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","article-title":"Five-year risk of stroke after tia or minor ischemic stroke","volume":"378","author":"Amarenco","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0002","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (colcot)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejps.2022.106288_bib0003","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2022.106288_bib0004","first-page":"1174","article-title":"Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"10.1016\/j.ejps.2022.106288_bib0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The low dose colchicine after myocardial infarction (lodoco-mi) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejps.2022.106288_bib0007","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehn608","article-title":"Colchicine for pericarditis: hype or hope?","volume":"30","author":"Imazio","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejps.2022.106288_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or tia","volume":"383","author":"Johnston","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk tia","volume":"379","author":"Johnston","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0010","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/STROKEAHA.120.033152","article-title":"Residual inflammatory risk predicts poor prognosis in acute ischemic stroke or transient ischemic attack patients","volume":"52","author":"Li","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ejps.2022.106288_bib0011","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/STROKEAHA.116.012901","article-title":"High-sensitive c-reactive protein predicts recurrent stroke and poor functional outcome: subanalysis of the clopidogrel in high-risk patients with acute nondisabling cerebrovascular events trial","volume":"47","author":"Li","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ejps.2022.106288_bib0012","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/eurheartj\/ehaa752","article-title":"The sooner, the better: anti-inflammation in acute myocardial infarction","volume":"41","author":"Luscher","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejps.2022.106288_bib0013","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity c-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejps.2022.106288_bib0014","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. College Cardiol."},{"key":"10.1016\/j.ejps.2022.106288_bib0015","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0016","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the solid-timi 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.ejps.2022.106288_bib0017","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2016.3609","article-title":"Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial","volume":"315","author":"O'Donoghue","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.ejps.2022.106288_bib0018","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation","volume":"120","author":"Park","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2022.106288_bib0019","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1161\/STROKEAHA.117.018045","article-title":"One-year outcomes after minor stroke or high-risk transient ischemic attack: Korean multicenter stroke registry analysis","volume":"48","author":"Park","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ejps.2022.106288_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity c-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial","volume":"33","author":"Raju","year":"2012","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ejps.2022.106288_bib0021","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of c-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the cantos randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2022.106288_bib0024","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress nlrp3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejps.2022.106288_bib0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejps.2009.09.004","article-title":"Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats","volume":"38","author":"Sharma","year":"2009","journal-title":"Eur. J. Pharm. Sci"},{"key":"10.1016\/j.ejps.2022.106288_bib0026","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0027","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The nlrp3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejps.2022.106288_bib0028","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: act coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ejps.2022.106288_bib0029","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/svn-2020-000369","article-title":"Association of elevated hs-crp and multiple infarctions with outcomes of minor stroke or tia: subgroup analysis of chance randomised clinical trial","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.ejps.2022.106288_bib0030","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0031","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in cyp2c19 loss-of-function carriers with stroke or tia","volume":"385","author":"Wang","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2022.106288_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/svn-2021-000885","article-title":"Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc. Neurol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:03:58Z","timestamp":1760529838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":32,"alternative-id":["S0928098722001737"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106288","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106288"}}